[HTML][HTML] Primary healthcare protects vulnerable populations from inequity in COVID-19 vaccination: An ecological analysis of nationwide data from Brazil
Background There is limited information on the inequity of access to vaccination in low-and-
middle-income countries during the COVID-19 pandemic. Here, we described the …
middle-income countries during the COVID-19 pandemic. Here, we described the …
[HTML][HTML] The COVID-19 Vaccination Strategy in Brazil—A Case Study
L Bernardeau-Serra, A Nguyen-Huynh, L Sponagel… - Epidemiologia, 2021 - mdpi.com
Brazil is among the countries which have faced two devastating infection waves of COVID-
19 in the past year. Despite the fact the country has one of the world's leading immunization …
19 in the past year. Despite the fact the country has one of the world's leading immunization …
[HTML][HTML] Impact of healthcare capacity disparities on the COVID-19 vaccination coverage in the United States: a cross-sectional study
DF Cuadros, JD Gutierrez, CM Moreno… - The Lancet Regional …, 2023 - thelancet.com
Background The impact of the COVID-19 vaccination campaign in the US has been
hampered by a substantial geographical heterogeneity of the vaccination coverage. Several …
hampered by a substantial geographical heterogeneity of the vaccination coverage. Several …
[HTML][HTML] The effectiveness of COVID-19 vaccines against severe cases and deaths in Brazil from 2021 to 2022: a registry-based study
CVB Dos Santos, NCM Valiati… - The Lancet Regional …, 2023 - thelancet.com
Background Brazil started the COVID-19 mass vaccination in January 2021 with CoronaVac
and ChAdOx1, followed by BNT162b2 and Ad26. COV2. S vaccines. By the end of 2021 …
and ChAdOx1, followed by BNT162b2 and Ad26. COV2. S vaccines. By the end of 2021 …
[HTML][HTML] The assistance gaps in combating COVID-19 in Brazil: For whom, where and when vaccination occurs
RS Moreira, EG Costa, LFR Dos Santos… - BMC Infectious …, 2022 - Springer
Background Following the emergence of the COVID-19 pandemic, the number of infected
Brazilian people has increased dramatically since February 2020, with Brazil being amongst …
Brazilian people has increased dramatically since February 2020, with Brazil being amongst …
[HTML][HTML] Estimating the impact of implementation and timing of the COVID-19 vaccination programme in Brazil: a counterfactual analysis
Background Vaccines developed between 2020 and 2021 against the SARS-CoV-2 virus
were designed to diminish the severity and prevent deaths due to COVID-19. However …
were designed to diminish the severity and prevent deaths due to COVID-19. However …
[HTML][HTML] The impact of delayed access to COVID-19 vaccines in low-and lower-middle-income countries
Introduction A majority of low-income (LIC) and lower-middle-income countries (LMIC) were
unable to achieve at least 10% population coverage during initial vaccine rollouts, despite …
unable to achieve at least 10% population coverage during initial vaccine rollouts, despite …
[HTML][HTML] COVID-19 vaccination, incidence, and mortality rates among indigenous populations compared to the general population in Brazil: Describing trends over …
FCG Machado, MM Ferron… - The Lancet Regional …, 2022 - thelancet.com
Background Chronic social and health inequities faced by indigenous peoples in Brazil
foretell the detrimental impact of COVID-19. Methods We use de-identified, publicly …
foretell the detrimental impact of COVID-19. Methods We use de-identified, publicly …
COVID-19 vaccination challenge: what have we learned from the Brazilian process?
Despite a long tradition of strong primary healthcare systems, some Latin American
countries—such as Brazil and Mexico—have suffered the worst during the pandemic …
countries—such as Brazil and Mexico—have suffered the worst during the pandemic …
Effectiveness of mass vaccination in Brazil against severe COVID-19 cases
Background Mass vaccination campaigns started in Brazil on January/2021 with CoronaVac
followed by ChAdOx1 nCov-19, and BNT162b2 mRNA vaccines. Target populations initially …
followed by ChAdOx1 nCov-19, and BNT162b2 mRNA vaccines. Target populations initially …